CN212134715U

CN212134715U - Integrated detection card for blood type and hemolytic disease of newborn

Info

Publication number: CN212134715U
Application number: CN202020717176.XU
Authority: CN
Inventors: 陈贞仙
Original assignee: Individual
Current assignee: Individual
Priority date: 2020-05-06
Filing date: 2020-05-06
Publication date: 2020-12-11
Anticipated expiration: 2030-05-06

Abstract

The utility model discloses a neonate's blood type and hemolytic disease integrated detection card, including three detection areas of a blood grouping district and hemolysis, the blood grouping district includes an ABO, RhD blood type detection examination strip, and the examination strip has set gradually a flushing area, a application of sample reaction zone, a water absorption district from upstream to downstream, and its characterized in that, application of sample reaction zone is equipped with A check point, B check point, D check point, and ABO, RhD blood type identification can be accomplished simultaneously to a drop sample; the hemolysis three detection areas comprise a red blood cell direct antiglobulin test detection part, a free antibody detection part and a red blood cell diffusion liquid detection part which are sequentially arranged side by side, each detection part comprises a test strip, and an IgG anti-A detection point and an IgG anti-B detection point are arranged in a test strip reaction area, so that the hemolyzing three detection areas can specifically detect immune blood type antibodies from a parent body, avoid the sensitized red blood cell washing step of a conventional liquid reagent, and have higher sensitivity; the utility model discloses be fit for the quick bedside detection of neonate's blood type and blood soluble disease.

Description

Integrated detection card for blood type and hemolytic disease of newborn

Technical Field

The utility model belongs to the technical field of blood detects, concretely relates to neonate's blood type and hemolytic disease comprehensive testing card.

Background

Hemolytic disease of the newborn (HDN) of the pediatrics is one of the most common acute hemolytic diseases, which means that blood types of mothers and infants are incompatible, fetal red blood cells stimulate the mothers, immune blood group antibodies are formed in pregnant mothers, mainly IgG type antibodies are used as main antibodies, the IgG antibodies can enter the fetuses through placentas to destroy the fetal red blood cells to cause HDN, serious patients can also have abortion, premature birth, dead fetus, hemolytic jaundice and severe anemia, and can develop into jaundice with jaundice, early death of infants or irreversible neurological sequelae left on survivors, and great pain is brought to the sick infants and families. The most common neonatal hemolytic disease with ABO blood group incompatibility found in the human blood group system so far is Rh blood group system, and HDN caused by other blood group systems is less common.

Items specifically requiring detection in the recommended protocol for postpartum immunohematology tests for neonatal Hemolytic Disease (HDN) published by the association of chinese physicians include: 1. ABO positive typing of newborn, RhD blood type, 2, Direct Antiglobulin Test (DAT) of newborn erythrocytes (detecting whether sensitized immune antibodies exist on newborn erythrocytes), 3, erythrocyte diffusion liquid antibody detection of newborn, 4, free antibody detection of newborn plasma (serum) (detecting whether immune antibodies from mothers exist in newborn serum), wherein the detection result is one of the most important evidences of clinical diagnosis and clinical treatment and is shown in Table 1.

TABLE 1 analysis of three test results of ABO blood group incompatibility with newborn and clinical significance

ABO positive typing and RhD blood grouping recommended in the recommendation scheme of neonatal Hemolytic Disease (HDN) postpartum immunohematology test are performed by adopting a liquid reagent test tube centrifugation method, and the operation steps are as follows: 1) taking 3 test tubes, respectively marking anti-A, anti-B and anti-D, 2) respectively adding corresponding antibody reagents, 3) adding 50ul of 2% -5% erythrocyte suspension of a sick child into each test tube, 4)1000g, centrifuging for 15s, and slightly shaking the test tubes to observe results. It has a number of disadvantages: 1) liquid reagent needs cold storage and cold chain transportation, is unfavorable for storing, 2), the sample needs the pretreatment, 3) needs extra centrifugal equipment, 4) needs to rock the test tube interpretation result, and the human factor influence is big, is unfavorable for the result interpretation. In addition, the blood group antigen detection methods commonly used in clinic include a microcolumn gel method and a solid phase card method, but all methods have various defects, such as: the method has the advantages of needing pretreatment of samples, needing independent sample adding and detection of each antigen, high cost, long detection time, large influence of subjective deviation on result interpretation, needing auxiliary equipment and the like.

The neonatal erythrocyte Direct Antiglobulin Test (DAT) recommended in the recommendation of neonatal Hemolytic Disease (HDN) postpartum immunohematology test also adopts a liquid reagent test tube centrifugation method, and the operation steps are as follows: 1) washing the erythrocytes of the children patient with saline for 3-4 times, preparing 2% -5% saline suspension, 2) taking 1 test tube, adding 50ul of the suspension, adding 100ul of anti-human globulin serum (anti-IgG), immediately mixing, centrifuging at 1000g for 15s, 3) slightly rotating the test tube, pouring the suspension on a glass slide, and observing the result under a low power microscope. It also has a number of disadvantages: 1) liquid reagent needs cold-stored and cold chain transportation, is unfavorable for storing, 2) needs extra centrifugal equipment, 3) needs to rock the test tube interpretation result, and the human factor influence is big, is unfavorable for the result interpretation. The micro-column gel method is also available in the market, but the method has the defects that: high cost, long detection time, need of auxiliary equipment and the like.

The detection of the neonatal serum free antibody and the erythrocyte diffusing liquid antibody recommended in the neonatal Hemolytic Disease (HDN) postpartum immunohematology test recommendation scheme also adopts a liquid reagent test tube centrifugation method, and the operation steps are as follows: 1) taking 1 test tube, adding 200ul of the radioactive liquid, 2) adding 50ul of standard red blood cells with 2% -5% of ABO type with children patients, uniformly mixing, 3) sensitizing in water bath at 37 ℃ for 1h, 4) taking out, washing with saline for 3 times, finally sucking water for 1 time, adding 100ul of an antiglobulin reagent into each tube, 5) centrifuging for 15s, and observing the result by naked eyes at 1000 g. It also has a number of disadvantages: 1) liquid reagents need refrigeration and cold chain transportation and are not beneficial to storage, 2) additional centrifugal equipment is needed, 3) long-time sensitization is needed, 4) tedious washing of sensitized erythrocytes is needed, and 5) test tube shaking is needed to interpret results, so that human factors have great influence and result interpretation is not beneficial. Because the determination process is too complex, a microcolumn gel card method is basically adopted in large hospitals, the steps of washing erythrocytes and interpreting results by a microscope can be omitted, but the whole process still consumes long time, and the steps are complicated and high in cost.

Disclosure of Invention

The utility model aims to overcome the defects of the prior art and provide a comprehensive detection card for newborn blood type and hemolytic disease.

The technical scheme of the utility model as follows:

a card for comprehensively detecting blood type and hemolytic disease of newborn is characterized in that: comprises that

A blood type identification area, which comprises an ABO and RhD blood type detection test strip, wherein the test strip is sequentially provided with a flushing area, a sample adding reaction area and a water absorption area from upstream to downstream, the detection test strip comprises a substrate, a reaction film arranged on the substrate, a sealing strip and a water absorption pad, the reaction film is arranged at the middle lower part of the substrate, the sealing strip is arranged at the middle part of the reaction film, the water absorption pad is arranged at the middle upper part of the substrate and is lapped on one end of the reaction film, the area from one end of the reaction film to one end of the sealing strip is the flushing area, the area of the reaction film between the other end of the sealing strip and one end of the water absorption pad is the sample adding reaction area, the water absorption pad forms the water absorption area, and the sample adding reaction area is provided with a detection point A;

a three-item hemolysis detection area comprises a newborn erythrocyte Direct Antiglobulin Test (DAT) detection part, a newborn erythrocyte diffusion liquid antibody detection part and a newborn free antibody detection part, wherein each detection part comprises a same test strip which is sequentially provided with a flushing area, a sample adding area, a reaction area and a water absorption area from upstream to downstream, the detection test strip comprises a substrate, a flushing pad, a reaction membrane, a water absorption pad and a sealing strip, the flushing pad, the reaction membrane, the water absorption pad and the sealing strip are arranged on the substrate, the reaction membrane is arranged in the middle of the substrate, one end of the flushing pad is lapped on one end of the reaction membrane, one end of the water absorption pad is lapped on the other end of the reaction membrane, one part of the sealing strip is pasted on the reaction membrane, the other part of the sealing strip is pasted on the flushing pad, the area of the flushing pad close to the sealing strip is the sample adding area, the area far away from the sealing strip is the flushing area, the area of the reaction membrane, which is arranged between one end of the sealing, the water absorption pad forms a water absorption area, and the sample adding reaction area is provided with an IgG anti-A detection point and an IgG anti-B detection point.

The utility model discloses an in a preferred embodiment, still include a shell, this shell corresponds washing area, application of sample reaction zone of ABO, RhD blood type testing strip have seted up corresponding washing hole, application of sample reaction hole respectively, and this shell corresponds corresponding washing area, application of sample zone, reaction zone of three items of testing strip of hemolysis have seted up corresponding washing hole, application of sample hole, reaction hole respectively.

In a preferred embodiment of the present invention, the a detection spot is coated with a cured anti-a antibody, the B detection spot is coated with a cured anti-B antibody, and the D detection spot is coated with a cured anti-D antibody.

In a preferred embodiment of the invention, the IgG anti-a detection spot is coated with immobilized anti-a antibody and the IgG anti-B detection spot is coated with immobilized anti-B antibody.

In a preferred embodiment of the present invention, the a detection point, the B detection point, and the D detection point are arranged linearly or triangularly along the lateral dispersion of the ABO and RhD blood type test strips, and the IgG anti-a detection point and the IgG anti-B detection point are arranged linearly along the lateral dispersion of the hemolysis three test strips.

In a preferred embodiment of the present invention, the D detection point is located in the middle, and the a detection point and the B detection point are arranged on the left and right sides of the D detection point.

In a preferred embodiment of the present invention, the reaction membrane is a backed porous composite membrane having a capillary flow rate of 50 to 110sec/4cm width.

The utility model has the advantages that:

1. the utility model discloses a neonate's blood type and hemolytic disease integrated detection card can be used for ABO, RhD blood grouping simultaneously to and three experiments of neonate's hemolysis, as solid phase reagent card, have a great deal of advantage, if: the kit is stored at room temperature, does not need auxiliary equipment, is convenient to operate, has the advantages of easy interpretation of results, short detection time, difficult pollution, high specificity and sensitivity and the like, and is suitable for rapid bedside detection of blood type and hemolytic disease of newborn children.

2. The utility model discloses a blood grouping district includes an ABO, RhD blood group test strip, and the examination strip simple structure, and the coating is solidified specific blood group antibody on the reaction film, and ABO, RhD blood group appraisal can be accomplished simultaneously to a drop sample, and the sample need not the pretreatment, and easy operation only needs 1 drop flush fluid, and check time is short to 1min to the anti-A antibody of solidification, the anti-B antibody of B check point coating solidification, the anti-D antibody of D check point coating solidification, and the sample.

3. The three hemolysis detection areas of the utility model comprise a newborn erythrocyte Direct Antiglobulin Test (DAT) detection part, a newborn erythrocyte diffusion liquid antibody detection test part and a newborn free antibody detection part, wherein each detection part comprises a same test strip, a reaction membrane is coated with a solidified specific blood type secondary antibody, an IgG anti-A detection point is coated with a solidified anti-A antibody, an IgG anti-B detection point is coated with a solidified anti-B antibody, the immunity blood type antibody from mother in the newborn serum can be ensured to be specifically detected, the interference of other non-anti-A and anti-B antibodies in a sample is effectively shielded, thereby the washing step of the sensitized erythrocyte like the conventional liquid reagent is not needed, the sensitivity is higher, and the IgG anti-A antibody and the IgG anti-B antibody can be simultaneously identified, unlike the conventional liquid reagent and the microcolumn gel card which can only be separately and independently detected.

4. The utility model discloses the reaction film who uses is the large aperture, ensures that single erythrocyte can pass through, consequently, direct whole blood application of sample when ABO, RhD blood grouping need not sample pretreatment, directly uses standard erythrocyte as the indicator during three detections of neonate's hemolysis to need not like the antigen preparation that traditional immunochromatography examination strip is the same, draw and indicator mark step, simplified the conversion production technology of product.

5. The utility model discloses the coating antibody all is the punctiform on the reaction film, and each check point is arranged along the width direction dispersion of examination strip, can avoid mutually interfering in the capillary flow to the upper phase, has reduced the steric hindrance when the sample flows through the reaction film, can shorten the length of reaction zone simultaneously, has greatly shortened check-out time, and the result can be deciphered to 1-3min after the flush fluid dropwise add.

Drawings

Fig. 1 is a schematic view of the appearance structure of the present invention.

Fig. 2 is a schematic exploded view of the ABO and RhD blood type test strips of the present invention.

Fig. 3 is a schematic exploded view of the three-dimensional structure of the hemolysis test strip of the present invention.

Fig. 4 is a graph showing the interpretation of the test results in embodiments 2 to 4 of the present invention.

Detailed Description

The technical solution of the present invention will be further illustrated and described below with reference to the accompanying drawings by means of specific embodiments.

Example 1

A card for comprehensively detecting newborn blood type and hemolytic disease comprises a shell 1, an ABO, RhD blood type detection test strip 4 and a tri-hemolytic three test strip 5.

As shown in fig. 1, 2 and 3, an ABO, RhD blood group test strip 4 and a housing 1 form a blood grouping area 2, three hemolysis test strips 5 and the housing 1 respectively form a newborn erythrocyte Direct Antiglobulin Test (DAT) detection portion 31, a newborn free antibody detection portion 32, a newborn erythrocyte diffusion liquid antibody detection portion 33, and the detection portion 31, the detection portion 32 and the detection portion 33 form a hemolysis detection area 3.

The ABO and RhD blood group test strip 4 is sequentially provided with a flushing area 421, a sample adding reaction area 422 and a water absorbing area 441 from upstream to downstream, and comprises a substrate 41, a reaction film 42 arranged on the substrate 41, a sealing strip 43 and a water absorbing pad 44, wherein the reaction film 42 is arranged at the middle lower part of the substrate 41, the sealing strip 43 is arranged at the middle part of the reaction film 42, the water absorbing pad 44 is arranged at the middle upper part of the substrate 41 and is lapped on one end of the reaction film 42, the area between one end of the reaction film 42 and one end of the sealing strip 43 is the flushing area 421, the area between the other end of the sealing strip 43 and one end of the water absorbing pad 44 of the reaction film 42 is the sample adding reaction area 422, the water absorbing pad 44 forms a water absorbing area 441, and the sample adding reaction area 422 is provided with a detection point 401, B detection point 403 and D detection; the shell 1 is provided with a flushing area 421 corresponding to the ABO and RhD blood type test strips 4, a flushing hole 21 of a sample adding reaction area 422 and a sample adding reaction hole 22 in sequence in the blood type identification area 2.

The hemolysis three items testing strip 5, from the upstream to the downstream, is provided with a flushing area 531, a sample adding area 532, a reaction area 520, a water absorbing area 551, which comprises a base plate 51, a flushing pad 53, a reaction membrane 52, a water absorbing pad 55 and a sealing tape 54, which are arranged on the base plate 51, the reaction membrane 52 is arranged on the middle part of the base plate 51, one end of the flushing pad 53 is lapped on one end of the reaction membrane 52, one end of the water absorbing pad 55 is lapped on the other end of the reaction membrane 52, one part of the sealing tape 54 is pasted on the reaction membrane 52, the other part is pasted on the flushing pad 53, the area of the flushing pad 53 close to the sealing tape 54 is the sample adding area 532, the area far away from the sealing tape 54 is the flushing area 531, the area of the reaction membrane 52 between one end of the sealing tape 54 and one end of the water absorbing pad 55 is the reaction area 520, the water absorbing pad 55 constitutes the water absorbing area 551, the reaction area, IgG anti-B detection point 522; the casing 1 is provided with a washing region 531, a sample adding region 532 and a washing hole 301, a sample adding hole 302 and a reaction hole 303 corresponding to the three hemolysis detection test strips 5, the three hemolysis detection zones 3 in sequence.

Preferably, the detection site A of the sample-adding reaction region 422 is coated with a cured anti-A antibody, the detection site B is coated with a cured anti-B antibody, the detection site D is coated with a cured anti-D antibody, and the detection site IgG of the reaction region 520 is coated with a cured anti-A antibody and the detection site IgG of the reaction region B is coated with a cured anti-B antibody.

The shell 1 is made of plastic, preferably one of PS, ABS and PET, and adopts a customized plastic card of Shanghai gold standard; the

water absorption pads

44 and 55 are made of water absorption materials, preferably cotton pulp paper, and any one of Shanghai gold mark SX-42 or Auger XJ-420, XJ-440 and XJ-520 is adopted; the

reactive membranes

42, 52 are large pore size porous composite membranes, preferably backed porous composite membranes having capillary flow rates of 50-110sec/4cm width, using AE99 or FF85.100 from Schleicher & Schuell; the rinse pad 53 is a hydrophilic porous support, preferably glass fiber, available from 8975 of Ahlstrom; the

substrates

41 and 51 are polyester plates, and the special polyester plates with adhesive of Shanghai gold labels are adopted; the

sealing tapes

43 and 54 are PP tapes, PE tapes, ABS tapes or PET tapes with adhesives, and four-dimensional precise non-standard transparent tapes are used.

anti-A antibody, anti-B antibody and anti-D antibody, wherein the corresponding blood type antibody of Merck is adopted; the anti-A antibody and the anti-B antibody are specific blood type secondary antibodies, are respectively combined with the IgG anti-A antibody and the IgG anti-B antibody in a specific immune mode, and adopt corresponding blood type secondary antibodies of Wuhanxinyuanzan.

Example 2

The newborn blood type and hemolytic disease comprehensive test card of example 1 is used for identifying newborn erythrocyte blood type, and specifically comprises the following steps:

(1) sample adding: adding 10ul of EDTA anticoagulation/sodium citrate anticoagulation venous blood to be detected for the newborn into a sample adding reaction hole 22 of the blood grouping area.

(2) Adding a flushing liquid: after sample application, wait 10 seconds, add 40-80ul of flushing fluid into the flushing well 21 of the blood grouping area.

(3) And (4) interpretation of results: waiting for 1 minute after adding the washing solution, and interpreting the result in the sample addition reaction well 22, wherein the detection point shows red color, which is a positive reaction, for example: the detection point A is red, namely the blood type is A type, the detection point B is red, namely the blood type is B type, and the detection point D is red, namely the blood type is D type; no color was developed at the detection point, and the reaction was negative. The specific result explanation is shown in figure 4.

Example 3

The method for detecting the presence or absence of sensitized immune antibodies on newborn erythrocytes by using the newborn blood type and hemolytic disease comprehensive detection card of example 1, namely, the erythrocyte Direct Antiglobulin Test (DAT), specifically comprises the following steps:

(1) sample preparation: the newborn red blood cells are washed 3-4 times with physiological saline to prepare 10% physiological saline suspension.

(2) Sample adding: 10ul of the above sample was added to the well 302 of the detection section of the neonatal erythrocyte Direct Antiglobulin Test (DAT).

(3) Adding a flushing liquid: after the sample addition, the sample was waited for 10 seconds, and 40 to 80ul of the washing solution was added to the washing well 301 of the detection part of the neonatal erythrocyte Direct Antiglobulin Test (DAT).

(4) And (4) interpretation of results: after adding the washing solution, waiting for 1 minute, and interpreting the result in the reaction well 303, wherein the detection point shows red color, which is a positive reaction, for example: the anti-A detection point shows red, namely the erythrocyte is sensitized by the IgG anti-A antibody, and the anti-B detection point shows red, namely the erythrocyte is sensitized by the IgG anti-B antibody; no color was developed at the detection point, and the reaction was negative. The specific result explanation is shown in figure 4.

Example 4

The method for detecting the neonatal erythrocyte diffusion liquid antibody by using the neonatal blood type and hemolytic disease comprehensive detection card in the embodiment 1 to further verify whether sensitized immune antibodies exist on the neonatal erythrocytes comprises the following steps:

(1) preparing a diffusing liquid: the neonatal erythrocyte sensitized antibody is dispersed into physiological saline by a physical method (changing temperature conditions) to obtain a dispersion liquid containing the sensitized antibody, and the operation steps are referred to 'recommendation scheme of neonatal Hemolytic Disease (HDN) immunohematology test'.

(2) Adding a dispersion sample: 10ul of the sample was added to the well 302 of the antibody detection part of the newborn erythrocyte lysate.

(3) Adding AB type standard red blood cells: 10ul of AB type erythrocytes added with 10% physiological saline suspension are added to the well 302 of the antibody detection part of the newborn erythrocyte diffusion solution.

(4) Adding a flushing liquid: after adding AB type standard red blood cells, the system waits for 5 minutes, and 40 to 80ul of washing solution is added to the washing hole 301 of the antibody detection part of the newborn erythrocyte diffusion solution.

(5) And (4) interpretation of results: after adding the washing solution, waiting for 1 minute, and interpreting the result in the reaction well 303, wherein the detection point shows red color, which is a positive reaction, for example: the detection point of the anti-A is red, namely IgG anti-A antibody exists in the diffusion liquid, so that the sensitization of the red blood cells by the IgG anti-A antibody is further illustrated, and the detection point of the anti-B is red, namely IgG anti-B antibody exists in the diffusion liquid, so that the sensitization of the red blood cells by the IgG anti-B antibody is further illustrated; no color was developed at the detection point, and the reaction was negative. The specific result explanation is shown in figure 4.

Example 5

The method for detecting the serum free antibody of the newborn by using the comprehensive detection card for the newborn blood type and the hemolytic disease in the embodiment 1 is used for detecting whether the serum free antibody of the newborn is from a mother or not, and specifically comprises the following steps:

(1) sample adding: a well 302 for measuring free antibody in newborn was added to 10ul of serum/plasma in newborn to be tested.

(2) Adding AB type standard red blood cells: 10ul of AB type erythrocytes added with 10% physiological saline suspension are added to the well 302 of the detection part of free antibody in newborn.

(3) Adding a flushing liquid: after adding AB type standard red blood cells, the system was waited for 5 minutes, and 40 to 80ul of the rinsing solution was added to the rinsing well 301 of the free antibody detecting part of the newborn.

(4) And (4) interpretation of results: after adding the washing solution, waiting for 1 minute, and interpreting the result in the reaction well 303, wherein the detection point shows red color, which is a positive reaction, for example: the anti-A detection point shows red, namely free IgG anti-A antibody exists in serum/plasma, and the anti-B detection point shows red, namely free IgG anti-B antibody exists in serum/plasma; no color was developed at the detection point, and the reaction was negative. The specific result explanation is shown in figure 4.

The above description is only a preferred embodiment of the present invention, and therefore should not be taken as limiting the scope of the invention, which is defined by the following claims and their equivalents, and the modifications thereof, such as: the immobilized anti-human IgG antibody coated on the detection point of the hemolytic three-item test strip is also within the scope of the present invention.

Claims

1. A card for comprehensively detecting blood type and hemolytic disease of newborn is characterized in that: comprises that

a three-item hemolysis detection area comprises a newborn erythrocyte Direct Antiglobulin Test (DAT) detection part, a newborn free antibody detection part and a newborn erythrocyte diffusion liquid antibody detection part, wherein each detection part comprises a same test strip which is sequentially provided with a flushing area, a sample adding area, a reaction area and a water absorption area from upstream to downstream, the detection test strip comprises a substrate, a flushing pad, a reaction membrane, a water absorption pad and a sealing strip, the flushing pad, the reaction membrane, the water absorption pad and the sealing strip are arranged on the substrate, the reaction membrane is arranged in the middle of the substrate, one end of the flushing pad is lapped on one end of the reaction membrane, one end of the water absorption pad is lapped on the other end of the reaction membrane, one part of the sealing strip is pasted on the reaction membrane, the other part of the sealing strip is pasted on the flushing pad, the area of the flushing pad close to the sealing strip is the sample adding area, the area far away from the sealing strip is the flushing area, the area of the reaction membrane, which is arranged between one end of the, the water absorption pad forms a water absorption area, and the sample adding reaction area is provided with an IgG anti-A detection point and an IgG anti-B detection point.

2. The integrated newborn blood type and hemolytic disease detection card according to claim 1, wherein: the washing area, the sample adding area and the reaction area of the shell corresponding to the three hemolysis detection test strips are respectively provided with corresponding washing holes, sample adding holes and reaction holes.

3. The integrated newborn blood type and hemolytic disease detection card according to claim 1, wherein: the A detection point is coated with a solidified anti-A antibody, the B detection point is coated with a solidified anti-B antibody, and the D detection point is coated with a solidified anti-D antibody.

4. The integrated newborn blood type and hemolytic disease detection card according to claim 1, wherein: the IgG anti-A detection point is coated with an immobilized anti-A antibody, and the IgG anti-B detection point is coated with an immobilized anti-B antibody.

5. The integrated newborn blood type and hemolytic disease detection card according to claim 1, wherein: the detection points A, B and D are arranged linearly or triangularly along the transverse dispersion of the ABO and RhD blood type detection test strips, and the detection points IgG and B are arranged linearly along the transverse dispersion of the hemolysis three detection test strips.

6. The integrated newborn blood type and hemolytic disease detection card according to claim 5, wherein the card comprises: the detection point D is centered, and the detection points A and B are arranged on the left side and the right side of the detection point D respectively.

7. The integrated newborn blood type and hemolytic disease detection card according to claim 1, wherein: the reaction membrane is a backed porous composite membrane with capillary flow rate of 50-110sec/4cm wide.